0NF7 logo

PCAS LSE:0NF7 Stock Report

Last Price

€8.05

Market Cap

€109.9m

7D

0%

1Y

n/a

Updated

06 Dec, 2023

Data

Company Financials

0NF7 Stock Overview

PCAS SA develops and produces complex molecules for life sciences and specialty chemicals markets. More details

0NF7 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance2/6
Financial Health1/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

PCAS SA Competitors

Price History & Performance

Summary of share price highs, lows and changes for PCAS
Historical stock prices
Current Share Price€8.05
52 Week High€8.05
52 Week Low€6.34
Beta0.37
1 Month Change0%
3 Month Changen/a
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO-16.50%

Recent News & Updates

Recent updates

Shareholder Returns

0NF7GB Life SciencesGB Market
7D0%-4.4%-1.5%
1Yn/a-27.0%3.5%

Return vs Industry: Insufficient data to determine how 0NF7 performed against the UK Life Sciences industry.

Return vs Market: Insufficient data to determine how 0NF7 performed against the UK Market.

Price Volatility

Is 0NF7's price volatile compared to industry and market?
0NF7 volatility
0NF7 Average Weekly Movementn/a
Life Sciences Industry Average Movement7.2%
Market Average Movement4.9%
10% most volatile stocks in GB Market10.6%
10% least volatile stocks in GB Market2.6%

Stable Share Price: 0NF7 has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine 0NF7's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
19621,178Jean-Louis Martinwww.pcas.com

PCAS SA develops and produces complex molecules for life sciences and technologies. The company was founded in 1962 and is headquartered in Longjumeau, France. PCAS SA is a subsidiary of Seqens SAS

PCAS SA Fundamentals Summary

How do PCAS's earnings and revenue compare to its market cap?
0NF7 fundamental statistics
Market cap€109.93m
Earnings (TTM)€8.76m
Revenue (TTM)€229.96m

12.5x

P/E Ratio

0.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0NF7 income statement (TTM)
Revenue€229.96m
Cost of Revenue€81.51m
Gross Profit€148.45m
Other Expenses€139.69m
Earnings€8.76m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.64
Gross Margin64.55%
Net Profit Margin3.81%
Debt/Equity Ratio2,725.7%

How did 0NF7 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/12/06 13:13
End of Day Share Price 2023/09/08 00:00
Earnings2023/06/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

PCAS SA is covered by 4 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Claire DerayKepler Cheuvreux
Harold De DeckerODDO BHF Corporate & Markets
Geoffroy MichaletPortzamparc BNP Paribas